share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

辉瑞 | 4:持股变动声明-高管 BOURLA ALBERT
美股SEC公告 ·  10/12 02:04

Moomoo AI 已提取核心信息

Pfizer Inc. (PFE) has reported a significant transaction involving its Chairman & CEO, Albert Bourla. According to the announcement, the transaction took place on October 10, 2024. However, the details regarding the number of shares, the nature of the shares, the transaction price, and the total value of the shares involved in the transaction were not disclosed. The report also did not specify the number of shares held by Bourla after the transaction. This information is crucial for investors to understand the potential impact of the transaction on their holdings and the market's perception of Pfizer's stock.
Pfizer Inc. (PFE) has reported a significant transaction involving its Chairman & CEO, Albert Bourla. According to the announcement, the transaction took place on October 10, 2024. However, the details regarding the number of shares, the nature of the shares, the transaction price, and the total value of the shares involved in the transaction were not disclosed. The report also did not specify the number of shares held by Bourla after the transaction. This information is crucial for investors to understand the potential impact of the transaction on their holdings and the market's perception of Pfizer's stock.
辉瑞公司(PFE)报告了一项涉及其董事长兼首席执行官Albert Bourla的重大交易。根据公告,交易发生在2024年10月10日。然而,关于交易涉及的股份数量、股份性质、交易价格以及交易涉及的股票总价值的具体细节并未披露。报告还未指明Bourla在交易后持有的股份数量。这些信息对于投资者了解交易对其持股的潜在影响以及市场对辉瑞股票的看法至关重要。
辉瑞公司(PFE)报告了一项涉及其董事长兼首席执行官Albert Bourla的重大交易。根据公告,交易发生在2024年10月10日。然而,关于交易涉及的股份数量、股份性质、交易价格以及交易涉及的股票总价值的具体细节并未披露。报告还未指明Bourla在交易后持有的股份数量。这些信息对于投资者了解交易对其持股的潜在影响以及市场对辉瑞股票的看法至关重要。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息